No abstract available
MeSH terms
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Diabetes Mellitus, Type 1 / chemically induced*
-
Diabetes Mellitus, Type 1 / diagnosis
-
Diabetes Mellitus, Type 1 / immunology
-
Humans
-
Hypophysitis / chemically induced*
-
Hypophysitis / diagnosis
-
Hypophysitis / immunology
-
Ipilimumab
-
Male
-
Melanoma / drug therapy*
-
Melanoma / immunology
-
Melanoma / secondary
-
Middle Aged
-
Risk Factors
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / immunology
-
Skin Neoplasms / pathology
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Ipilimumab
-
pembrolizumab